Experience Using Adjuvant Bacteriophage Therapy for the Treatment of 10 Recalcitrant Periprosthetic Joint Infections: A Case Series.

James B DoubAaron J JohnsonSumon NandiVincent NgTheodore MansonMyounghee LeeBenjamin Chan

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

Periprosthetic joint infections are a devastating complication of joint replacement surgery. One novel therapeutic that has potential to change the current treatment paradigm is bacteriophage therapy. Herein, we discuss our experiences with bacteriophage therapy for 10 recalcitrant periprosthetic joint infections and review the treatment protocols utilized to achieve successful outcomes.

Keyphrases

minimally invasive
mental health
stem cells
metabolic syndrome
adipose tissue
risk assessment
coronary artery disease
skeletal muscle
acute coronary syndrome